Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06525701 · ClinicalTrials.gov registry record · NA
Surgeon Core-strengthening Program as a Modifier for Exertion Associated With Vaginal Surgery
A NA study of Musculoskeletal Pain and Musculoskeletal Injury, sponsored by Loyola University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT06525701: Completed NA study of Musculoskeletal Pain and Musculoskeletal Injury, sponsored by Loyola University.
NCT06525701 is a NA study of Musculoskeletal Pain and Musculoskeletal Injury that has completed, run by Loyola University. The registered enrollment target is 18 participants, below the 155-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06525701, a NA study of Musculoskeletal Pain and Musculoskeletal Injury, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Work-related musculoskeletal pain and injury is a growing concern in surgery. Vaginal surgery has unique ergonomic risks, but no studies have addressed the potential for an exercise regimen to reduce physical strain by vaginal surgeons
Primary Outcome
The effect of a core-strengthening program on surgeons' physical exertion during and after vaginal prolapse surgery as measured by the Borg Category Ratio (CR-10). The Borg Category Ratio scale is a self-reported tool that describes level of exertion and ranges from 0-10 where larger numbers represent greater exertion.
Conditions Studied
Interventions
- OTHER Control Group
- OTHER Execise Group
Study Locations (1)
Illinois
- Loyola University Medical Center - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2024-08-12 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
What the finished NCT06525701 record still lists
NCT06525701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 155-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Musculoskeletal Pain appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.
NCT06525701 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06525701 about?
NCT06525701 is a clinical study titled "Surgeon Core-strengthening Program as a Modifier for Exertion Associated With Vaginal Surgery". Work-related musculoskeletal pain and injury is a growing concern in surgery. Vaginal surgery has unique ergonomic risks, but no studies have addressed the potential for an exercise regimen to reduce physical strain by vaginal surgeons
What is the current status of trial NCT06525701?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2024-08-12. Estimated completion is 2025-07-01.
What conditions does trial NCT06525701 study?
This clinical trial studies the following conditions: Musculoskeletal Pain, Musculoskeletal Injury.
What interventions are being tested in trial NCT06525701?
The interventions under investigation include: Control Group (OTHER), Execise Group (OTHER).
Who is sponsoring clinical trial NCT06525701?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06525701 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Musculoskeletal Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06525701's enrollment target sits among peer trials
18 34th of 37 higher than 4 of 37 other Musculoskeletal Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Mechanisms and Modulation of Pain Modulatory Capacity
RECRUITING · NA
-
Equipping Patients Using Interventions for Pain and Depression
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI